Thus, HER2 positive breast cancer cells SK-BR-3 were chosen for the verification of the biological potential of indicated compounds to modulate breast cancer cells’ survival, invasive, and metastatic potential. This evidence concerns the gene ERBB2 and breast carcinoma.